| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |